Great experience, being talking to oneself!
5 Mio shares changing hands shortly before the close: I cannot imagine any other institution than the Liechtenstein fund selling, which owned some 25+ % of Endosonics (if I remember correctly) early this summer. I hope it won't be Kam aswell, but they had "only" 750'000 shares as of end of July. I think the Liechtenstein fund bought as-well (earlier this year) shares previously hold by WFC (some 5% of outstanding). All in all this could make up to 5 mio shares (16 Mio shares outstanding).
If the Liechtenstein guys sell it's probably a good buying opportunity; It an European fund with a new top management (earlier this year), and they are by no means specialists in this field. Don't know how they got into ESON in the first place, that was probably the same question asked by the relatively new management. (Cave: this is my own speculation, no supporting background information; but it makes sense to me).
4,5 USD is practically an all-time low, and the fundamentals for the company are improving (IVBT, angioplasty vs stenting, recent positive earnings surprise, share-buyback announcement by ESON);
PS: % of insider ownership? |
